Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases

BACKGROUND: Kras mutation has been associated with shorter overall survival and time to disease recurrence after resection of colorectal liver metastases (CLM). This study evaluated the prognostic value of Kras mutation in patients with CLM treated by percutaneous radiofrequency ablation (RFA). METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Shady, Waleed, Petre, Elena N., Vakiani, Efsevia, Ziv, Etay, Gonen, Mithat, Brown, Karen T., Kemeny, Nancy E., Solomon, Stephen B., Solit, David B., Sofocleous, Constantinos T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630397/
https://www.ncbi.nlm.nih.gov/pubmed/29029497
http://dx.doi.org/10.18632/oncotarget.19806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630397/
https://www.ncbi.nlm.nih.gov/pubmed/29029497
http://dx.doi.org/10.18632/oncotarget.19806

Ejemplares similares